SEC Form 4 · accession 0001104659-17-040822
Hepion Pharmaceuticals, Inc. · HEPA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John T Cavan
Officer — CFO
Period of report
Jun 20, 2017
Accepted (ET)
Jun 22, 2017 · 9:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 20, 2017 | P | 20,000 | $0.65 | A | 20,000 | D |
Table II — derivative securities
No Table II lines on this filing.